These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21073313)

  • 21. Intramuscular Immunization of Streptococcus pyogenes SF370 protein extract and identification of multiple virulence factors through proteomic profiling in RHD induced Balb/c mice.
    Arul Joseph Raj NB; Selvaraj S; Jebaseelan J; Motarwar AA; Rathinavel Andiappan GP; Selvam GS
    Microb Pathog; 2020 Mar; 140():103888. PubMed ID: 31770569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococci.
    Good MF; Pandey M; Batzloff MR; Tyrrell GJ
    Expert Rev Vaccines; 2015; 14(11):1459-70. PubMed ID: 26485214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Streptococcus pyogenes Transcriptome Changes in the Inflammatory Environment of Necrotizing Fasciitis.
    Hirose Y; Yamaguchi M; Okuzaki D; Motooka D; Hamamoto H; Hanada T; Sumitomo T; Nakata M; Kawabata S
    Appl Environ Microbiol; 2019 Nov; 85(21):. PubMed ID: 31471300
    [No Abstract]   [Full Text] [Related]  

  • 24. Functional analysis of Streptococcus pyogenes nuclease A (SpnA), a novel group A streptococcal virulence factor.
    Chang A; Khemlani A; Kang H; Proft T
    Mol Microbiol; 2011 Mar; 79(6):1629-42. PubMed ID: 21231972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of cryptic epitopes in designing a group A streptococcal vaccine.
    Ozberk V; Pandey M; Good MF
    Hum Vaccin Immunother; 2018; 14(8):2034-2052. PubMed ID: 29873591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. tRNA modification by GidA/MnmE is necessary for Streptococcus pyogenes virulence: a new strategy to make live attenuated strains.
    Cho KH; Caparon MG
    Infect Immun; 2008 Jul; 76(7):3176-86. PubMed ID: 18426891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of potential universal vaccine candidates against group A Streptococcus by using high throughput in silico and proteomics approach.
    Sharma A; Arya DK; Sagar V; Bergmann R; Chhatwal GS; Johri AK
    J Proteome Res; 2013 Jan; 12(1):336-46. PubMed ID: 23181284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular biology of Group A
    Brahmadathan NK
    Indian J Med Microbiol; 2017; 35(2):176-183. PubMed ID: 28681803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status of group A streptococcal vaccine development.
    Dale JB
    Adv Exp Med Biol; 2008; 609():53-63. PubMed ID: 18193657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein adhesins as vaccine antigens for Group A Streptococcus.
    Raynes JM; Young PG; Proft T; Williamson DA; Baker EN; Moreland NJ
    Pathog Dis; 2018 Mar; 76(2):. PubMed ID: 29718270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conserved anchorless surface proteins as group A streptococcal vaccine candidates.
    Henningham A; Chiarot E; Gillen CM; Cole JN; Rohde M; Fulde M; Ramachandran V; Cork AJ; Hartas J; Magor G; Djordjevic SP; Cordwell SJ; Kobe B; Sriprakash KS; Nizet V; Chhatwal GS; Margarit IY; Batzloff MR; Walker MJ
    J Mol Med (Berl); 2012 Oct; 90(10):1197-207. PubMed ID: 22527883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive Mass Spectrometric Survey of Streptococcus pyogenes Subcellular Proteomes.
    Wilk L; Happonen L; Malmström J; Herwald H
    J Proteome Res; 2018 Jan; 17(1):600-617. PubMed ID: 29160079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physicochemical characterisation, immunogenicity and protective efficacy of a lead streptococcal vaccine: progress towards Phase I trial.
    Pandey M; Powell J; Calcutt A; Zaman M; Phillips ZN; Ho MF; Batzloff MR; Good MF
    Sci Rep; 2017 Oct; 7(1):13786. PubMed ID: 29062085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development.
    Sanderson-Smith M; De Oliveira DM; Guglielmini J; McMillan DJ; Vu T; Holien JK; Henningham A; Steer AC; Bessen DE; Dale JB; Curtis N; Beall BW; Walker MJ; Parker MW; Carapetis JR; Van Melderen L; Sriprakash KS; Smeesters PR;
    J Infect Dis; 2014 Oct; 210(8):1325-38. PubMed ID: 24799598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Group A
    Young PG; Raynes JM; Loh JM; Proft T; Baker EN; Moreland NJ
    Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30936156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A decade of molecular pathogenomic analysis of group A Streptococcus.
    Musser JM; Shelburne SA
    J Clin Invest; 2009 Sep; 119(9):2455-63. PubMed ID: 19729843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FbaA- and M protein-based multi-epitope vaccine elicits strong protective immune responses against group A streptococcus in mouse model.
    Ma C; Liu Z; Li W; Qian X; Zhang S; Gao X; Jiang S; Wei L
    Microbes Infect; 2014 May; 16(5):409-18. PubMed ID: 24704476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptome Remodeling Contributes to Epidemic Disease Caused by the Human Pathogen Streptococcus pyogenes.
    Beres SB; Kachroo P; Nasser W; Olsen RJ; Zhu L; Flores AR; de la Riva I; Paez-Mayorga J; Jimenez FE; Cantu C; Vuopio J; Jalava J; Kristinsson KG; Gottfredsson M; Corander J; Fittipaldi N; Di Luca MC; Petrelli D; Vitali LA; Raiford A; Jenkins L; Musser JM
    mBio; 2016 May; 7(3):. PubMed ID: 27247229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endopeptidase PepO Regulates the SpeB Cysteine Protease and Is Essential for the Virulence of Invasive M1T1 Streptococcus pyogenes.
    Brouwer S; Cork AJ; Ong CY; Barnett TC; West NP; McIver KS; Walker MJ
    J Bacteriol; 2018 Apr; 200(8):. PubMed ID: 29378883
    [No Abstract]   [Full Text] [Related]  

  • 40. Virulence factor prediction in Streptococcus pyogenes using classification and clustering based on microarray data.
    López-Kleine L; Torres-Avilés F; Tejedor FH; Gordillo LA
    Appl Microbiol Biotechnol; 2012 Mar; 93(5):2091-8. PubMed ID: 22307501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.